Home > Boards > US OTC > Biotechs > Revance Therapeutics, Inc. (RVNC)

FWIW (and it may be very little), on

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
marthambles Member Profile
 
Followed By 6
Posts 925
Boards Moderated 0
Alias Born 04/26/04
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2021 4:34:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 7:56:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 7:54:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 7:52:54 PM
Revance to Participate in Upcoming Virtual Healthcare Conferences Business Wire - 5/26/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/26/2021 8:04:50 AM
Revance Provides Update on DaxibotulinumtoxinA for Injection Pre-Approval Inspection Business Wire - 5/26/2021 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2021 4:42:24 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2021 4:11:10 PM
Revance Therapeutics EPS beats by $0.11, beats on revenue Seeking Alpha - 5/10/2021 4:10:14 PM
Revance Reports First Quarter 2021 Financial Results, Provides Corporate Update Business Wire - 5/10/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 7:15:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 7:13:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 7:11:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 7:09:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 7:07:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2021 7:04:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2021 4:07:04 PM
Revance to Release First Quarter 2021 Financial Results on Monday, May 10, 2021 Business Wire - 5/3/2021 8:00:00 AM
Revance to Showcase Clinical Findings at The Aesthetic Meeting 2021 that Supports DaxibotulinumtoxinA’s 24-Week Long Durati... Business Wire - 4/27/2021 4:05:00 PM
Enrollment underway in Revance Therapeutics' late-stage DaxibotulinumtoxinA study Seeking Alpha - 4/27/2021 8:35:27 AM
Revance Announces First Patient Enrolled for DaxibotulinumtoxinA in Glabellar Lines & Cervical Dystonia in China by Fosun Pha... Business Wire - 4/27/2021 8:00:00 AM
Revance to Present Data on DaxibotulinumtoxinA for Injection & Hyaluronic Acid Fillers at American Academy of Dermatology VMX... Business Wire - 4/23/2021 8:00:00 AM
Revance signs supply agreement with contract manufacturer Lyophilization Seeking Alpha - 4/12/2021 4:32:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/6/2021 7:42:27 PM
marthambles   Wednesday, 02/24/21 01:51:46 PM
Re: DewDiligence post# 1786
Post # of 2009 
FWIW (and it may be very little), on Feb. 2 I posted the following on Twitter in response to Biomaven's speculation that its reasonably likely that the FDA had been hacked and it might be profitable to look out for any unusual share price activity:

"I will throw $RVNC into the ring as a possible hack. The shares were rising steadily in anticipation of Daxi approval and then suddenly, in mid and late Sept. it cratered over 30%. On November 25, a delay in the FDA facility inspection was announced.

Today, $RVNC is up over 6% and someone bought 500 April 35 calls. If the inspection takes place around this time, it would be logical that an approval might come before the April call expiration. Just speculation of course, but certainly consistent with Peter's premise".

500 is a lot of calls. I didn't see any evidence that it was part of a paired trade.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences